GPhA is a trade / professional association based in Washington, DC that was founded in 2000. As of 2019 they had $26 million in revenue and $11 million in assets.
Generic Pharmaceutical Association is the nation's leading trade association for manufacturers and distributors of generic drugs, bulk active chemicals and suppliers to the industry.
Previous legal names or variations of their name include: Generic Pharmaceutical Association.
Government affairs - advocate on behalf of the generic pharmaceutical and biosimilar industry with respect to federal, state, and municipal rules, laws, and orders affecting the industry.
Communications & marketing - educating policymakers, media, patients and other stakeholders about the economic and therapeutic contributions of generic and biosimilar Medicines as well as their safety and efficacy; producing and sharing patient and taxpayer savings data and stories of patients whose health is saved, improved and maintained by generic and biosimilar Medicines; disseminating instructional materials and curriculum to promote the safe use, storage and disposal of prescription Medicines.
Policy & strategic alliances - identify policy issues affecting the generic drug and biosimilars industries and facilitate development of policy positions among our member companies; work with the agencies of the u.s. government, and state and international bodies to educate and communicate policy positions on strategic priorities; develop data to support advocacy initiatives and publish white papers, reports and other policy resources; build relationships with third-party stakeholders across supply chain, patient, provider, consumer, and other sectors to support advocacy initiatives.
Fiscal year ending | Date received by IRS | Form | PDF link |
---|---|---|---|
2018-12 | Feb 3, 2020 | 990O | View PDF |
2017-12 | Feb 21, 2019 | 990 | View PDF |
2016-12 | Jan 18, 2018 | 990 | View PDF |
2015-12 | Dec 20, 2016 | 990O | View PDF |
2014-12 | Feb 1, 2016 | 990O | View PDF |
...and five more Form 990 PDFs |
Field | 2018 |
---|---|
Total grants, contributions, etc. | $0 |
Program services | $26,560,230 |
Investment income and dividends | $8,640 |
Tax-exempt bond proceeds | $0 |
Royalty revenue | $0 |
Net rental income | $0 |
Net gain from sale of non-inventory assets | $0 |
Net income from fundraising events | $0 |
Net income from gaming activities | $0 |
Net income from sales of inventory | $0 |
Miscellaneous revenues | $510 |
Total revenues | $26,569,380 |
Vendor | Services | Amount paid | Date |
---|---|---|---|
Councilor Buchanan and Mitchell PC | Tax accounting | 2019-11-13 | |
█████████ ████████ | Software | 2019-08-29 | |
██████ | Content management system software | 2019-08-21 | |
████████ ███ █████ | Legal Services | $770,004 | 2018-12-01 |
███████ ███████ ███ | Legal Services | $651,651 | 2018-12-01 |
██████ | Public Education Campaign | $800,000 | 2018-12-01 |
█████████ ██████████ ███ | Communications and Public Affairs Consul | $527,000 | 2018-12-01 |
█████ █ ███ | State and Federal Digital Strategy and E | $498,500 | 2018-12-01 |
...and one more vendors |
Name | Title | Compensation | Most recent data |
---|---|---|---|
Chester G Davis | President and Chief Executive Officer | $1.1 million | Feb. 3, 2020 |
Allen Goldberg | Vice President , Communications | $272,165 | May 27, 2020 |
████ ███████████████ | Vice President , Corporate Development and Administration | $421,538 | May 27, 2020 |
███████████████ ████ | Senior Vice President , Development and Administration | $555,897 | Dec. 31, 2018 |
█████ ██████ | Vice President, Policy | - | May 27, 2020 |
█████ █████ | Senior Vice President , Sciences and Regulatory Affairs | $631,236 | Dec. 31, 2018 |
████ █████ | Vice President, Sciences and Regulatory Affairs | - | May 27, 2020 |
████ █████████ | Vice President, Federal Government Affairs | - | May 27, 2020 |
█████████ ████ | Vice President , Federal Government Affairs | $337,633 | Dec. 31, 2018 |
█████ █████ | Director , Operations | - | May 27, 2020 |
...and 26 more key personnel |